Burlacu Maria Cristina, Tichomirowa Maria, Daly Adrian, Beckers Albert
Service d'endocrinologie, CHU de Liège, Université de Liège, Domaine universitaire du Sart-Tilman, B-4000 Liège, Belgique.
Presse Med. 2009 Jan;38(1):112-6. doi: 10.1016/j.lpm.2008.09.011. Epub 2008 Nov 5.
Familial pituitary adenomas are found in multitumoral syndromes such as multiple endocrine neoplasia type 1 (NEM1) and type 4 (NEM4) and the Carney complex (CNC); it remains at present the only known condition in the category of familial isolated pituitary adenomas (FIPA). Familial adenomas account for 3-5% of all pituitary adenomas. Their pathogenesis is known in part: mutations of the menin gene in NEM1 (80%), of the CDKN1B gene in NEM4 (several cases described), of the PRKR1A gene in CNC (50%) and the AIP gene in 15% of FIPA cases (50% of the FIPA cases with a homogeneous somatotropic phenotype). The clinical course of familial adenoma with NEM1 or FIPA is more aggressive than that of sporadic adenoma, with more macroadenomas and more patients diagnosed younger. Familial pituitary adenomas are distinguished from the sporadic forms in their genetic, epidemiologic and clinical characteristics. They require a differentiated management, especially concerning screening.
家族性垂体腺瘤见于多肿瘤综合征,如1型多发性内分泌腺瘤病(MEN1)、4型多发性内分泌腺瘤病(MEN4)和卡尼综合征(CNC);目前它仍是家族性孤立性垂体腺瘤(FIPA)类别中唯一已知的病症。家族性腺瘤占所有垂体腺瘤的3%至5%。其发病机制部分已知:MEN1中menin基因的突变(80%)、MEN4中CDKN1B基因的突变(已描述数例)、CNC中PRKR1A基因的突变(50%)以及15%的FIPA病例中AIP基因的突变(50%具有均匀生长激素表型的FIPA病例)。伴有MEN1或FIPA的家族性腺瘤的临床病程比散发性腺瘤更具侵袭性,大腺瘤更多,且更多患者在年轻时被诊断出来。家族性垂体腺瘤在遗传、流行病学和临床特征方面与散发性形式有所不同。它们需要差异化管理,尤其是在筛查方面。